Columbia Entrepreneurship

Columbia Design Studio: Intro to Design Thinking
2016-02-12 14:00 - 16:00 UTC
Columbia Design Studio
Workshop
Join us for a two-hour Design Thinking primer
Free Registration
Friday, February 12th
2:00 to 4:00 pm
Please join us as we introduce a framework for practicing design thinking. We will focus on needfinding, problem framing, rapid idea generation, and collaboration. The session is fast paced and equally valuable for individuals or teams.

What: An introduction to the creative tools and mindsets of design thinking.

Who: Open to ANYONE interested in human centered design.
When: Friday, February 12th from 2pm to 4pm.
Where: Riverside Church Room 430.

Questions: designstudio@columbia.edu
Free Registration: https://cdsintro2designthinkingspring16.eventbrite.com

Biopharma Perspective on Early Venture Investing and R&D
2016-02-11 12:00 - 14:00
Marian Nakada Ph.d,
Vice President Johnson & Johnson Innovation
Shafique Virani,
Global Head of Neuroscience, Ophthalmology & Rare Disease, Roche
and
Steven Weinstein
Managing Partner, Novartis Venture Fund
in conversation with
Orin Herskowitz, Executive Director Columbia Technology Ventures

February 11, 2016
12:00 Noon
On the Morningside Campus of Columbia University
Schapiro CEPSR, 4th Floor, Davis Auditorium

Register Today

Join Columbia Technology Ventures for a lively conversation that will touch on the various ways Big Pharma & Biotech are using venture capital investing, regional innovation centers, joint ventures, university research sponsorship, and IP licensing to source their next blockbuster products (as well as generate equity returns). The panelists will share their perspectives on venture capital investing strategies in biopharma, how to pitch strategic investors, the surge in biotech IPOs, hot research areas within biopharma, and best practices for establishing R&D partnerships between industry and academia.
This event is co-sponsored by the Lang Center for Entrepreneurship, Columbia Entrepreneurship, and the Healthcare and Pharmaceutical Management Program at Columbia Business School.
Marian Nakada, Vice President, Venture Investments, Johnson & Johnson Innovation, Marian Nakada, Ph.D, Vice President, Venture Investments, joined Johnson & Johnson Innovation – JJDC, Inc. (JJDC) in 2013. She is based in Boston, Mass. and focuses on pharmaceutical investments in East Coast companies that will create options in areas of strategic interest to Johnson & Johnson. Marian previously held roles in Centocor, Janssen R&D and Janssen Business Development. She has authored 62 peer-reviewed publications and 14 book chapters and reviews. She has a B.A. in Biology from Harvard College and a Ph.D in Pharmacology from the University of Pennsylvania and currently sits on the boards of Navitor Pharmaceuticals and Padlock Therapeutics.
Shafique Virani, Global Head of Neuroscience, Ophthalmology & Rare disease (NORD) Partnering, Roche
Dr. Virani’s responsibilities in this role encompass all partnering activities within Roche’s NORD franchise, from academic collaborations to licensing and acquisitions. The NORD partnering group has executed several key partnering transactions on behalf of Roche over the past five years, including collaborations with ReMynd, Evotec, Seaside Therapeutics, PTC Therapeutics, Inception 3, Inception 5, ISIS, Laval University, Prothena and acquisition of Trophos.
Dr. Virani joined Roche in 2004 and served various roles within medical affairs, marketing and business development in the UK, USA and Switzerland until 2012, when he transitioned into his current role based in South San Francisco. Dr. Virani trained as a neurosurgeon in Cambridge, UK and Boston, Mass. and holds the Fellowship of the Royal College of Surgeons of England.
Steven Weinstein, Managing Partner, Novartis Venture Fund
Steven D. Weinstein is a Managing Director in Cambridge, Mass. Steve focuses on both medical device and therapeutic investments for the fund. Prior to joining NVF, he was a Principal at Prism Venture Partners where he focused on medical devices. Prior to Prism, Steve was a Principal and Kauffman Fellow with Mid-Atlantic Venture Funds. He started his career as turnaround CEO, raising angel funds to buy the assets of a defunct distribution business out of bankruptcy and subsequently rebuilding the business. Steve holds an MBA with distinction from the University of Michigan Business School and a B.S. in mechanical engineering from Columbia University’s School of Engineering and Applied Science. He serves on the Partner’s Healthcare Innovation Advisory Board and the University of Michigan Wolverine Venture Fund Advisory Board. Steve serves on the boards of Advanced Animal Diagnostics, Autonomic Technologies, Innocrin, Intersection Medical and Viamet.

Columbia Startup Lab Programming: Founders Series with Jamie Hodari '04CC
2016-02-03 17:30 - 18:30
Columbia Startup Lab Programming:
Founders Series with Jamie Hodari ’04CC

Wednesday, February 3 @ 5:30 PM
@ Columbia Startup Lab
REGISTER NOW
The Founders Series in the Columbia Startup Lab will run throughout the year and will feature Start up founders who are eager to discuss their own successes and even failures with the Columbia community. If you are a young entrepreneur, anxious to learn first-hand knowledge of what it takes to make it in the startup world, this series is exactly what you are looking for.
Jamie is the Co-Founder and Co-CEO of Industrious. Prior to Industrious, Jamie was the CEO and Co-Founder of Kepler, a rapidly growing experimental university that Scientific American called a “daring global experiment” to bring “top-tier instruction to the neediest parts of the planet.” Jamie previously ran the education non-profit Generation Rwanda, analyzed investments at the hedge fund Birch Run Capital and was a project finance lawyer at the law firm Sullivan & Cromwell. He started his career as a journalist at the Times of India. Jamie lives in Brooklyn but will travel as far as necessary for Szechuan food or good standup comedy. Jamie holds a J.D. from Yale Law School, an M.P.P. from Harvard University, and a B.A. from Columbia University.
REGISTER NOW

Columbia Startup Lab Programming: How To Build A Financial Plan Investors Will Love
2015-12-01 12:30 - 14:30
How To Build A Financial Plan Investors Will Love
with
Early Growth Financial Services founder and CEO David Ehrenberg

Tuesday, December 1 @ 12:30 pm
@ The Columbia Startup Lab
Lunch will be provided
REGISTER TODAY!
Need some help defining your financial plan so that investors just can’t say no? If so, this is a can’t miss workshop for you!
If your financials aren’t telling a compelling story and you need help with financial projections and financial planning, please join us for this one-hour long session during which we’ll discuss the importance of milestone funding, the components of your financial model, top-down and bottom-up financial projections, creating your budget, and more.
David Ehrenberg founded Early Growth Financial Services (EGFS) in 2008 to address the lack of on-demand financial support available to startups. David’s passion for mentoring entrepreneurs, and helping early-stage startups to thrive, led him to create the integrated financial solution that EGFS provides, from day-to-day accounting to strategic finance, tax, and valuation support.
Prior to founding EGFS, David was the first CFO for Abound Logic, playing an integral role in building out the company’s finance and administrative infrastructure. Before that, David was a Controller for Microsoft, in a division that focused on creating new products and business solutions. Earlier in his career, David was a key member of the finance team at Extreme Networks and Voice Stream Wireless and VP of Finance for Radiant Research, where he was responsible for selling the company in two transactions and ensuring a successful exit for investors and management.
After graduating from Georgetown University with degrees in accounting and finance, David started his career on Wall Street doing mergers and acquisitions work for Deloitte & Touche. He went on to earn his MBA from the University of Washington.
REGISTER TODAY!

Design Sprint: Developing Early Stage Startup Ideas
2015-11-13 13:00 - 15:00
Design Sprint: Developing Early Stage Startup Ideas
With Adam Royalty, Designer in Residence
Register Here
What: A two week sprint focusing on founder idea fit and customer exploration
When: Founder idea fit; Friday 11/13/15, 1pm — 3pm. Customer Exploration; Friday 11/20/15, 1pm — 3pm.
Where: Room 430 Riverside Church; There is a central elevator bank that you can assess from Claremont Street. Go to the fourth floor and turn left.
This sprint is designed for students who have a problem they are excited to solve or an idea they want to explore. This is also an opportunity for students who may not have an venture in mind but want to help work on someone else’s.
The first session will focus on flushing out ideas and figuring out how to use the strenghts of a founding team. Applying design tools to uncover needs and frame problems will highlight the second session.
Note: it is recommended, but not required, that people experience both sessions.

Columbia Startup Lab Programming: Build More, Build Faster Without Building Your Engineering Team
2015-11-04 17:00 - 19:00
Build More, Build Faster Without Building Your Engineering Team
With Amol Sarva ’98CC

Wednesday, November 4 @ 5:00 pm
@ The Columbia Startup Lab
REGISTER TODAY!
The limiting factor for today’s fast paced technology startups is access to quality engineers. Come hear serial creator Dr. Amol Sarva ’98CC share his tips and tricks for building more, faster with the same or fewer engineers.
Dr. Amol Sarva is an American technology entrepreneur who co-founded Peek and Virgin Mobile USA. He is currently developing a new cognitive enhancement technology called Halo Neuro and an application for better discussions called Knotable. He’s an advisor to Fon, the world’s largest wifi network. He also advises Payfone (mobile payments), Work Market (platform for labor resources), and Ouya (open source game console).
Amol co-founded Peek as its CEO through worldwide product launches and raised over $25 million from top venture capital firms including RRE Ventures and Bharti SoftBank (which acquired it in 2012). He’s an original member of the Founders’ Roundtable in New York, a group of 300+ venture-backed startup founders that has met monthly since 2006, and has touched dozens of VC-backed startups and many of the top founders in NYC. He has been named multiple times to the Silicon Alley 100 list of top New York entrepreneurs. He is a mentor for the NYC Seed venture capital fund’s SeedStart program. Amol received his Ph.D. from Stanford University and B.A. from Columbia University.
REGISTER TODAY!
